Diabetic Cardiomyopathy Clinical Trial
Official title:
Mechanisms Responsible for Cardiac and Skeletal Muscle Energetic Impairment in Diabetes
Diabetes increases the risk of heart failure. This is mainly due to a disease of the blood vessels supplying the heart muscle and/or high blood pressure, but abnormal metabolism may also contribute. We plan to study the mechanisms involved in this abnormal metabolism, whilst also assessing the effects of a drug called Perhexiline which improves the abnormal metabolism that is present in diabetic patients before the development of heart failure.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01803828 -
REmodelling in Diabetic CardiOmapathy: Gender Response to PDE5i InhibiTOrs
|
Phase 4 | |
Completed |
NCT05102851 -
Impact of Prediabetes on Acute Coronary Syndrome
|
||
Active, not recruiting |
NCT03904485 -
Assessment of Myocardial Injury in Simultaneous Pancreas and Kidney Transplantation
|